
Integrated Medicines Private Limited
About Integrated Medicines Private Limited
Data last updated:
Integrated Medicines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 September 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1991PTC063322. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sanjay Ramchandra Dhadve and Bhavesh Nagindas Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 1 Hiralaya 19th Ashoknagar Chsl 10th Road Laxmikant Chowk Jvpd Vile Parle West, Mumbai, Maharashtra, India – 400049.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Integrated Medicines Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 1 Hiralaya 19th Ashoknagar Chsl 10th Road Laxmikant Chowk Jvpd Vile Parle West, Mumbai, Maharashtra, India – 400049
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Integrated Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Integrated Medicines is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Integrated Medicines Private Limited, buy the company report.
Financials of Integrated Medicines Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Integrated Medicines Private Limited, buy the company report.
Board of directors of Integrated Medicines Private Limited
Integrated Medicines has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asha Prakash Khatiwala | Additional Director | 21 Mar 2014 | 12 Years 7 Months | Current |
| Sanjay Ramchandra Dhadve Also directs: Arlex Chemi Private Limited | Director | 20 May 2004 | 22 Years 5 Months | Current |
| Bhavesh Nagindas Shah | Director | 20 Mar 2008 | 18 Years 7 Months | Current |
Auditor
Integrated Medicines Private Limited is audited by SHAH&BHOSALE for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH&BHOSALE | FY 2022 | 129657W |
Shareholding
The shareholding of Integrated Medicines Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Integrated Medicines Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Integrated Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Integrated Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Integrated Medicines has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Integrated Medicines Private Limited, buy the company report.
Recent activity
Integrated Medicines Private Limited has 4 board changes on record since 2004: 3 appointments and 1 cessation. The latest: Asha Prakash Khatiwala was appointed as Additional Director on 21 Mar 2014.
Frequently asked questions
Integrated Medicines is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 September 1991 (35+ years old) and is registered under CIN U24239MH1991PTC063322.
Integrated Medicines has 3 current directors:
- Asha Prakash Khatiwala - Additional Director
- Sanjay Ramchandra Dhadve - Director
- Bhavesh Nagindas Shah - Director
The latest financial statements of Integrated Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Integrated Medicines has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Integrated Medicines is U24239MH1991PTC063322. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Integrated Medicines was incorporated on 19 September 1991, making it 35+ years old. It is registered with the Registrar of Companies, Mumbai.
Asha Prakash Khatiwala was appointed as Additional Director on 21 Mar 2014. Bhavesh Nagindas Shah was appointed as Director on 20 Mar 2008. Zuber Ahmed Dadulla Jagirdar ceased to be Director on 20 Mar 2008. Integrated Medicines has 4 board changes on record in total.
The registered office of Integrated Medicines is at G – 1 Hiralaya 19th Ashoknagar Chsl 10th Road Laxmikant Chowk Jvpd Vile Parle West, Mumbai, Maharashtra, India – 400049.
Integrated Medicines operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Integrated Medicines is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.

